Overview

Pharmacokinetic Study of Primaquine in Healthy Obese Thai Adult Subjects

Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to provide a description of the pharmacokinetic properties of primaquine and metabolites and characterize these in healthy obese Thai subjects. This is an open-label, single dose pharmacokinetic study in 10 healthy obese G6PD normal, subjects will be admitted as inpatient to receive 1 regimen for 1 visit only.
Phase:
Phase 1
Details
Lead Sponsor:
University of Oxford
Treatments:
Primaquine